Azitra Inc., a biopharmaceutical company that’s developing treatments for skin diseases, filed for an initial public offering on Tuesday with ThinkEquity...
Azitra Inc., a biopharmaceutical company that’s developing treatments for skin diseases, filed for an initial public offering on Tuesday with ThinkEquity acting as sole underwriter on the deal. The Branford, Connecticut-based company will use the proceeds of the deal to fund clinical trials and product development, including $2.5 million that’s earmarked for the ATR-12 Netherton syndrome program, which will provide funding for dosing in a proposed Phase 1b trial.
The Branford, Connecticut-based company will use the proceeds of the deal to fund clinical trials and product development, including $2.5 million that’s earmarked for the ATR-12 Netherton syndrome program, which will provide funding for dosing in a proposed Phase 1b trial. Netherton is a rare disorder that causes severe inflammation, scaling, red and dehydrated skin, for which there is currently no FDA-approved treatment option. The company, like many early-stage biotechs, is loss-making.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
BioCube plants life science flag in North San Jose - Silicon Valley Business JournalBioCube’s Tony Gonzalez thinks San Jose is a great place for biotech firms to call home.
Consulte Mais informação »
BioCube plants life science flag in North San Jose - Silicon Valley Business JournalBioCube’s Tony Gonzalez thinks San Jose is a great place for biotech firms to call home.
Consulte Mais informação »
Goldman Sachs upgrades Vir Biotechnology, says shares can more than double post-CovidThe firm said the immunology company will release new flu vaccine data in the year ahead that could drive growth for the biotech stock.
Consulte Mais informação »
China formalizes rules for overseas IPOsThe new rules also call for IPO underwriters, typically international investment banks, to annually report to the CSRC their involvement with Chinese listings overseas.
Consulte Mais informação »
Going Private Again Is All the Rage Among Newly Public CompaniesTen companies that went public in 2020 or 2021 have already agreed to go private in another sign of a post-IPO-boom hangover.
Consulte Mais informação »
Elusive Chinese Billionaire Jack Ma Spotted In Australia, Report SaysMa has almost completely disappeared from public view after Chinese regulators shut down his fintech company Ant Group’s IPO in late 2020.
Consulte Mais informação »